First Time Loading...
D

Decibel Therapeutics Inc
NASDAQ:DBTX

Watchlist Manager
Decibel Therapeutics Inc
NASDAQ:DBTX
Watchlist
Price: 4.91 USD Market Closed
Updated: May 6, 2024

Income Statement

Earnings Waterfall
Decibel Therapeutics Inc

Revenue
0 USD
Operating Expenses
-66m USD
Operating Income
-66m USD
Other Expenses
2.6m USD
Net Income
-63.4m USD

Income Statement
Decibel Therapeutics Inc

Rotate your device to view
Income Statement
Currency: USD
Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023
Revenue
Revenue
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
Operating Income
Operating Expenses
(37)
(36)
(54)
(59)
(50)
(50)
(53)
(59)
(60)
(64)
(64)
(66)
Selling, General & Administrative
(14)
(13)
(21)
(23)
(21)
(20)
(22)
(23)
(24)
(24)
(23)
(24)
Research & Development
(23)
(23)
(33)
(35)
(30)
(30)
(31)
(36)
(37)
(40)
(41)
(42)
Operating Income
(37)
N/A
(36)
+2%
(54)
-50%
(59)
-8%
(50)
+14%
(50)
+0%
(53)
-6%
(59)
-10%
(60)
-3%
(64)
-6%
(64)
0%
(66)
-3%
Pre-Tax Income
Interest Income Expense
0
0
0
0
0
0
0
0
1
1
2
3
Non-Reccuring Items
(4)
(3)
(4)
(3)
0
0
0
0
0
0
0
0
Total Other Income
0
0
0
0
0
0
0
0
0
0
0
0
Pre-Tax Income
(40)
N/A
(39)
+3%
(58)
-47%
(62)
-7%
(50)
+19%
(50)
+0%
(53)
-6%
(58)
-10%
(60)
-2%
(63)
-5%
(62)
+1%
(63)
-2%
Net Income
Tax Provision
0
0
0
0
(2)
(2)
(2)
(2)
(0)
(0)
(0)
(0)
Income from Continuing Operations
(40)
(39)
(58)
(62)
(52)
(52)
(55)
(60)
(60)
(63)
(62)
(63)
Net Income (Common)
(54)
N/A
7
N/A
(17)
N/A
(18)
-7%
1
N/A
(54)
N/A
(55)
-2%
(60)
-10%
(60)
+1%
(63)
-5%
(62)
+1%
(63)
-2%
EPS (Diluted)
-2.24
N/A
0.29
N/A
-1.37
N/A
-0.71
+48%
0.02
N/A
-2.49
N/A
-2.21
+11%
-2.42
-10%
-2.4
+1%
-2.52
-5%
-2.49
+1%
-2.54
-2%

See Also

Discover More